In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates

被引：5

作者：

Kantarcioglu, AS ^{[1
]}

Yucel, A

Vidotto, V

机构：

[1] Univ Istanbul, Cerrahpasa Med Fac, Dept Microbiol & Clin Microbiol, TR-34303 Cerrahpasa, Turkey

[2] Univ Turin, Clin Microbiol Sect, Medicosurg Dept, I-10124 Turin, Italy

来源：

JOURNAL OF CHEMOTHERAPY | 2003年 / 15卷 / 03期

关键词：

D O I：

10.1179/joc.2003.15.3.296

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：296 / 298

页数：3

共 15 条

[1]

BARNETT JA, 1990, YEASTS CHARACTERISTI, P111

[2]

BODEY GP, 1999, INFECT DIS REV, V1, P4

[3]

Amide derivatives of partricin A with potent antifungal activity [J].

Bruzzese, T ;

Rimaroli, C ;

Bonabello, A ;

Ferrari, E ;

Signorini, M .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (12) :965-972

[4]

Canela, 1995, INTRO FOOD BORNE FUN

[5]

Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study [J].

Espinel-Ingroff, A ;

Chaturvedi, V ;

Fothergill, A ;

Rinaldi, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) :3776-3781

[6]

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :954-958

[7]

GALLIS HA, 1990, REV INFECT DIS, V12, P308

[8]

Kantarcioglu A. Serda, 2002, Cerrahpasa Tip Dergisi, V33, P7

[9]

*NAT COMM CLIN LAB, 1998, M38P NAT COMM CLIN L, P7

[10]

*NAT COMM LAB REF, 1997, M27A NAT COMM LAB RE

← 1 2 →